DeVinney Erick Wayne Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$317,644.04

Insider Activity of DeVinney Erick Wayne

According to the SEC Form 4 filings, DeVinney Erick Wayne, being in a position of

  1. Chief Innovation Officer at AxoGen, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 24738 shares for $780,544,
    over all time since 2020-12-21, has bought 0 shares, and sold 46600 shares for $1.12M.

Biography of DeVinney Erick Wayne

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$780,5442100

Comparison of Insiders on Amount of Buys and Sells

2026-03-16SaleAxoGen, Inc.
AXGN
Chief Innovation Officer
5,221
0.0101%
$32.84$171,458+27.44%
2025-12-09SaleAxoGen, Inc.
AXGN
Chief Innovation Officer
19,517
0.0433%
$31.21$609,087+27.44%
2025-09-16SaleAxoGen, Inc.
AXGN
Chief Innovation Officer
1,137
0.0024%
$16.29$18,522+102.81%
2025-03-19SaleAxoGen, Inc.
AXGN
Chief Innovation Officer
15,111
0.0333%
$17.50$264,443-4.13%
2024-03-21SaleAxoGen, Inc.
AXGN
Chief Innovation Officer
4,578
0.0106%
$7.68$35,159+71.45%
2020-12-29SaleAxoGen, Inc.
AXGN
VP, Clinical&Translational Sc
742
0.0019%
$17.81$13,215+8.43%
2020-12-21SaleAxoGen, Inc.
AXGN
VP, Clinical&Translational Sc
294
0.0007%
$16.42$4,827+11.1%
Total: 7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.